Journal of Modern OncologyJournal of Modern Oncology1815-14341815-1442LLC Obyedinennaya Redaktsiya26716Research ArticleANAPLASTIChESKAYa KRUPNOKLETOChNAYa LIMFOMA VZROSLYKh:VLIYaNIE PROGNOSTIChESKIKh FAKTOROV NA TERAPIYuSemenovaA A-SorokinE N-PoddubnayaI V-ProbatovaN A-TimofeevaO L-15062008102444709042020Copyright © 2008, Consilium Medicum2008крупноклеточная лимфомахимиотерапия[Stein H, Mason D.Y., Gerdes J et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–58.][Stein H, Foss H.D., Durkop H et al. CD 30+ anaplastic large - cell lymphoma a revive of its histopathologic, genetic, and clinical features. Blood 2000; 96 (12): 3681–95.][Durkop H, Latza U, Hummel M et al. Molecular cloning and expression of new member of the herve drowth factor receptor family that is characteristic for Hodgkin disease. Cell 1992; 68: 421.][Falini B, Pileri S, Zinzani P.L. et al. ALK+ lymphoma: clinico - pathological findings and outcome. Blood 1999; 93: 2697–706.][Williams D.M., Hobson R, Imeson J et al. Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol 2002; 117: 812–20.][Seidemann K, Tiemann M, Schrappe M et al. Short - pulse B-non-Hodgkin lymphoma - type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 2001; 97: 3699–706.][Fisher R.I., Gaynor E.R., Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non- Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–6.]